Knees next for Mesoblast
Tuesday, 12 August, 2008
Preclinical trials conducted by Mesoblast [ASX: MSB] have shown that the company's adult stem cells are capable of regenerating damaged knee cartilage in a post-menopausal osteoarthritis large animal model.
A single injection of adult stem cells was able to repair and regenerate knee cartilage in ewes with well established osteoarthritis even though the cells were administered three months after initial joint damage.
This effect has yet to be demonstrated by any competing products on the market, the company said.
Mesoblast executive director Professor Silviu Itescu said the results meant the company would now target both post-menopausal and post-traumatic knee osteoarthritis for product commercialisation.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
